Page last updated: 2024-10-25

cilostazol and Spinal Cord Diseases

cilostazol has been researched along with Spinal Cord Diseases in 1 studies

Spinal Cord Diseases: Pathologic conditions which feature SPINAL CORD damage or dysfunction, including disorders involving the meninges and perimeningeal spaces surrounding the spinal cord. Traumatic injuries, vascular diseases, infections, and inflammatory/autoimmune processes may affect the spinal cord.

Research Excerpts

ExcerptRelevanceReference
"These results indicate that cilostazol is neuroprotective in the chronically compressed cervical cord and is potentially useful in the treatment of cervical spondylotic myelopathy."7.80Cilostazol, a selective Type III phosphodiesterase inhibitor: prevention of cervical myelopathy in a rat chronic compression model. ( Kim, P; Kurokawa, R; Yamamoto, S, 2014)
"These results indicate that cilostazol is neuroprotective in the chronically compressed cervical cord and is potentially useful in the treatment of cervical spondylotic myelopathy."3.80Cilostazol, a selective Type III phosphodiesterase inhibitor: prevention of cervical myelopathy in a rat chronic compression model. ( Kim, P; Kurokawa, R; Yamamoto, S, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yamamoto, S1
Kurokawa, R1
Kim, P1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Regeneration in Cervical Degenerative Myelopathy - a Multi-centre, Double-blind, Randomised, Placebo Controlled Trial Assessing the Efficacy of Ibudilast as an Adjuvant Treatment to Decompressive Surgery for Degenerative Cervical Myelopathy[NCT04631471]Phase 3400 participants (Anticipated)Interventional2021-12-22Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for cilostazol and Spinal Cord Diseases

ArticleYear
Cilostazol, a selective Type III phosphodiesterase inhibitor: prevention of cervical myelopathy in a rat chronic compression model.
    Journal of neurosurgery. Spine, 2014, Volume: 20, Issue:1

    Topics: Animals; Cervical Vertebrae; Cilostazol; Disease Models, Animal; Male; Neurons; Phosphodiesterase 3

2014